Grants and Contributions:
Title:
Materials for improved Cryoprotection of Cells and Cell Containing Devices
Agreement Number:
1034409
Agreement Value:
$500,000.00
Agreement Date:
Jul 1, 2025 - Apr 30, 2026
Description:
The current project advances the manufacturing readiness of Allarta’s Microgel Technology using scale-up engineering methodologies. Additionally, Allarta is extending the market penetration potential of its cell encapsulation devices through cold-chain solutions, allowing for the scale-up and commercial application of cell therapies beyond life-threatening illnesses which can bear the burden of ‘just-in-time’ production logistics.
Organization:
National Research Council Canada
Expected Results:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Location:
Dundas, Ontario, CA L9H 2E7
Reference Number:
172-2025-2026-Q2-1034409
Agreement Type:
Contribution
Report Type:
Grants and Contributions
Recipient Business Number:
735566085
Recipient Type:
For-profit organization
Recipient's Operating Name:
Allarta
Recipient's Legal Name:
Allarta Life Science Inc.
Federal Riding Name:
Hamilton West--Ancaster--Dundas
Federal Riding Number:
35038
Program:
Industrial Research Assistance Program – Contributions to Firms
Program Purpose:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Coverage:
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation.
NAICS Code:
54171